Patients with depression sometimes try multiple medications without finding relief, necessitating a different medical approach. A doctor will evaluate your medical history, and they may suggest alternative therapies. Spravato is a prescription medication used in specific clinical scenarios. Here is more information on questions to ask your doctor about treatment-resistant depression and Spravato:
What Is Treatment-resistant Depression?
Treatment-resistant depression occurs when a patient does not respond adequately to at least two different antidepressant medications. A physician evaluates the patient’s medical history to determine if the current treatment plan is ineffective. When standard medications fail, doctors may recommend alternative therapies such as Spravato.
Some patients with depression experience persistent symptoms, and these symptoms interfere with daily functioning. During a medical visit, a patient should ask their doctor if their specific diagnosis qualifies as treatment-resistant depression. Medical professionals use defined diagnostic criteria to make this clinical determination.
What Is Spravato?
Spravato is a prescription nasal spray, and it contains the active ingredient esketamine. It is approved by the Food and Drug Administration for adults with treatment-resistant depression. Doctors administer this medication in a certified healthcare setting alongside an oral antidepressant, which helps the patient achieve symptom relief.
Patients should ask their doctor about the specific indications for this medication. A physician will review the patient’s history, and they may explain the drug’s pharmacological profile. This discussion helps clarify the medication’s clinical parameters, aiding the development of an effective treatment plan.
How Does It Work?
Esketamine targets the N-methyl-D-aspartate receptor in the brain. This action alters neurotransmitter activity, and it may help restore neural connections. Patients benefit from asking their doctor how this mechanism differs from traditional selective serotonin reuptake inhibitors. Traditional antidepressants often take weeks to show effects, but esketamine can sometimes produce more rapid changes, which helps patients with severe depressive episodes.
What Does the Process Involve?
The treatment process begins with a medical consultation, during which the doctor will assess your mental health history. On treatment days, you administer the nasal spray yourself under the observation of a healthcare provider. The provider monitors your blood pressure, and you must remain in the clinic for at least two hours.
Patients cannot drive themselves home after the session, so a caregiver or transportation service must be arranged. The initial treatment phase usually involves sessions twice a week for four weeks. After this initial period, the frequency of administration typically decreases. Your doctor evaluates your progress regularly and adjusts the treatment schedule based on clinical outcomes.
How Is Professional Guidance Beneficial?
A qualified healthcare provider monitors for adverse reactions, and they adjust the treatment plan based on clinical observations. Doctors evaluate the ongoing efficacy of the treatment protocol. A patient can ask their physician how clinical progress is measured, and the doctor will explain the specific assessment tools used. Consistent medical oversight supports a structured approach to managing treatment-resistant depression.
Talk to Your Doctor Today
Spravato requires careful clinical evaluation, and a thorough medical consultation initiates the process. Patients with treatment-resistant depression should discuss their full medical history with a qualified provider. Schedule an appointment with your doctor to review your treatment options and determine if this medication is appropriate.
